Advertisement

Topics

Novel Antibodies against a Ground-Breaking New Target for the Treatment of Cardiovascular ...

23:06 EST 13 Nov 2017 | BioMedReports - Blog

Abzena PLC
John Burt, CEO
+44 1223 903498
or
Campbell Bunce, SVP Scientific Operations
Min Park, Global Head of Marketing
+1 267 54 7752
or
Instinctif Partners (Abzena)
Melanie Toyne Sewell / Alex Shaw / Deborah Bell
+44 20 7457 2020
abzena@instinctif.com
or
Enleofen Bio Pte Ltd
Stuart Cook, Co-Founder
info@enleofen.com

Read more...

Original Article: Novel Antibodies against a Ground-Breaking New Target for the Treatment of Cardiovascular ...

NEXT ARTICLE

More From BioPortfolio on "Novel Antibodies against a Ground-Breaking New Target for the Treatment of Cardiovascular ..."

Advertisement
Quick Search
Advertisement
Advertisement